Deferiprone as a second line treatment in myelodysplastic syndromes. Case report

被引：0
|
作者：
Iastrebner, M. [1 ]
Flores, A.
Quiroga, L.
Beligoy, L.
Colimodio, R. [2 ]
机构：
[1] San Luis Med Ctr, Buenos Aires, DF, Argentina
[2] CDTHO Mercedes Buenos Aires, Buenos Aires, DF, Argentina
来源：
LEUKEMIA RESEARCH | 2009年 / 33卷
关键词：
D O I：
10.1016/S0145-2126(09)70182-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：S118 / S118
页数：1
相关论文
共 50 条
  • [41] Circulating dendritic cells of the patients with myelodysplastic syndromes.
    Shao, Zonghong
    Wang, Huaquan
    Xing, Limin
    Fu, Rong
    Tu, Fengmei
    BLOOD, 2007, 110 (11) : 221B - 221B
  • [42] Cytologic aspects and current nosography of myelodysplastic syndromes.
    Flandrin, G
    PATHOLOGIE BIOLOGIE, 1997, 45 (07): : 545 - 549
  • [43] Delayed responses to thalidomide in patients with myelodysplastic syndromes.
    Lisak, LA
    Little, L
    Dean, L
    Ekbal, M
    duRandt, M
    Hussain, M
    Kaistha, V
    Raza, A
    BLOOD, 2000, 96 (11) : 261B - 261B
  • [44] Myelodysplastic syndromes. Incidence and survival in Republic of Armenia
    Daghbashyan, S.
    Sahakyan, L.
    Kabasakalyan, E.
    LEUKEMIA RESEARCH, 2013, 37 : S41 - S41
  • [45] Biologic characteristics of patients with hypocellular myelodysplastic syndromes.
    Goyal, R
    Qawi, H
    Ali, SI
    Dar, S
    Mundle, S
    Ahmed, B
    Quadri, M
    Naseer, OB
    Andrews, C
    Shetty, V
    Mativi, B
    Altampallam, K
    Lisak, L
    Loew, J
    Venugopal, P
    Gezer, S
    Robin, E
    Rifkin, S
    Raza, A
    BLOOD, 1998, 92 (10) : 629A - 629A
  • [46] Abnormal lipid profiles in patients with myelodysplastic syndromes.
    Allampallam, K
    Dutt, D
    Nair, C
    Shetty, V
    Mundle, S
    Lisak, L
    Andrews, C
    Ahmed, B
    Mazzone, L
    Zorat, F
    Borok, R
    Muzammil, M
    Akber, A
    Gundroo, A
    Ansaarie, I
    Raza, A
    BLOOD, 1999, 94 (10) : 282B - 282B
  • [47] Terminal deoxynucleotidyl transferase expression in myelodysplastic syndromes.
    Fan, G
    Mazzella, FM
    KowalVern, A
    Wibowo, A
    Mikhael, A
    Schumacher, HR
    BLOOD, 1997, 90 (10) : 4037 - 4037
  • [48] Phenotypic changes in cytogenetically abnormal myelodysplastic syndromes.
    Szczarkowski, W
    Stelzer, G
    Shults, K
    Stone, E
    Mixon, C
    Braylan, RC
    BLOOD, 1997, 90 (10) : 4052 - 4052
  • [49] Iron Metabolism and Erythropoietic Stress in Myelodysplastic Syndromes.
    Santini, Valeria
    Sanna, Alessandro
    Duca, Lorena
    Gozzini, Antonella
    Girelli, Domenico
    Cortelezzi, Agostino
    Reda, Gianluigi
    Campostrini, Natascia
    Cappellini, Maria Domenica
    BLOOD, 2009, 114 (22) : 696 - 696
  • [50] Functional disturbance of marrow microenvironment in myelodysplastic syndromes.
    Tauro, S
    Hepburn, MD
    Peddie, CM
    Bowen, DT
    Pippard, MJ
    EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 455 - 455
12345